ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme Borreliosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03010228
Recruitment Status : Active, not recruiting
First Posted : January 4, 2017
Last Update Posted : May 22, 2018
Sponsor:
Information provided by (Responsible Party):
Valneva Austria GmbH

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : September 28, 2017
  Estimated Study Completion Date : January 2019